l-Carnitine enhances resistance to oxidative stress by reducing DNA damage in Ataxia telangiectasia cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 650, Issue 2, 2008, Pages 165-174

  Berni, Andrea ^a   Meschini, Roberta ^a   Filippi, Silvia ^a   Palitti, Fabrizio ^a   De Amicis, Andrea ^b   Chessa, Luciana ^b  

^a UNIVERSITY OF TUSCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ataxia telangiectasia; Chromosomal damage; DNA repair; l Carnitine; Oxidative stress

Indexed keywords

CARNITINE; MANNITOL;

ARTICLE; ATAXIA TELANGIECTASIA; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; HUMAN; HUMAN CELL; MITOSIS RATE; PRIORITY JOURNAL;

ATAXIA TELANGIECTASIA; CARNITINE; CELL CYCLE; CELL LINE; CHROMOSOME ABERRATIONS; COMET ASSAY; DNA DAMAGE; HUMANS; MITOTIC INDEX; OXIDATIVE STRESS;

ATAXIA TELANGIECTASIA;

EID: 39049171760     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.11.008     Document Type: Article

References (35)

1. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Teagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Fridman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G., Taylor A.M., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., and Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 (1995) 1749-1753
2. Andegeko Y., Moyal L., Mittelman L., Tsarfaty I., Shiloh Y., and Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276 (2001) 38224-38230
3. Abraham R.T. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
4. 2 checkpoint function in human fibroblasts. J. Biol. Chem. 276 (2001) 21951-21959
5. Evans M.D., and Cooke M.S. Factors contributing to the outcome of oxidative damage to nucleic acids. BioEssays 26 (2004) 533-542
6. Guidarelli A., Brambilla L., Clementi E., Sciorati C., and Cantoni O. Stimulation of oxygen consumption promotes mitochondrial calcium accumulation, a process associated with, and causally linked to, enhanced formation of tert-butyl-hydroperoxide-induced DNA single-strand breaks. Exp. Cell Res. 237 (1997) 176-185
7. Von Sonntag C. The Chemical Basis of Radiation Biology (1987), Taylor and Francis, London p. 515
8. Offord E., van Poppel G., and Tyrrell R. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic. Res. 33 suppl. (2000) S5-S19
9. Cadet J., Bourdat A.G., D'Ham C., Duarte V., Gasparutto D., Romieu A., and Ravanat J.L. Oxidative base damage to DNA: specificity and base excision repair enzymes. Mutat. Res. 462 (2000) 121-128
10. Ramsay R.R. The role of the carnitine system in peroxisomal fatty acid oxidation. Am. J. Med. Sci. 318 (1999) 28-35
11. Vaz F.M., and Wanders R.J.A. Carnitine biosynthesis in mammals. Biochem. J. 361 (2002) 417-429
12. Reznick A.Z., Kagan V.E., Ramsey R., Tsuchiya M., Khwaja S., Serbinova E.A., and Packer R. Antiradical effects in l-propionyl carnitine protection of the hearth against ischemia-reperfusion injury: the possible role of iron chelation. Arch. Biochem. Biophys. 296 (1992) 394-401
13. Singh R.B., Niaz M.A., Agarwal P., Beegum R., Rastogi S.S., and Sachan D.S. A randomised, double-blind, placebo-controlled trial of l-carnitine in suspected acute myocardial infarction. Post-grad. Med. J. 72 (1996) 45-50
14. Vescovo G., Ravara B., Gobbo V., Sandri M., Angelini A., Della Barbera M., Dona M., Peluso G., Calvani M., Mosconi L., and Dalla Libera L. l-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in hearth failure. Am. J. Physiol. Cell Physiol. 283 (2002) 802-810
15. Binienda Z., and Ali S.F. Neuroprotective role of l-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol. Lett. 125 (2001) 67-73
16. Boerrigter M., Franceschi C., Arrigoni-Martelli E., Wei J.Y., and Vijg J. The effect of l-carnitine and acetyl-l-carnitine on the disappearance of DNA single-strand breaks in human peripheral blood. Carcinogenesis 14 (1993) 2131-2136
17. Vanella A., Russo A., Acquaviva R., Campisi A., Di Giacomo G., Sorrenti V., and Barcellona M.L. l-Propionyl-carnitine as superoxide scavenger, antioxidant, and cleavage protector. Cell Biol. Toxicol. 16 (2000) 99-104
18. Lorenti Garcia C., Filippi S., Mosesso P., Calvani M., Nicolai R., Mosconi L., and Palitti F. The protective effect of l-carnitine in peripheral blood human lymphocytes exposed to oxidative agents. Mutagenesis 21 (2006) 21-27
19. Regoli F., and Winston G.W. Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol. Appl. Pharmacol. 156 (1999) 96-105
20. Watters D., Kedar P., Spring K., Bjorkman J., Chen P., Gatei M., Birrel G., Garrone B., Srinivasa P., Crane D.I., and Lavin M.F. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274 (1999) 34277-34282
21. Winston G.W., Harvey W., Berl L., and Cederbaum A.I. The generation of hydroxyl and alkoxyl radicals from the interaction of ferrous bipyridyl with peroxides. Biochem. J. 216 (1983) 415-421
22. Fairbairn D.W., Olive P.L., and O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 388 (1997) 33-44
23. Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., Rotman G., Smith S., Chessa L., Jorgensen T.J., Harnik R., Frydman M., Sanal O., Portnoi S., Goldwicz Z., Jaspers N.G., Gatti R.A., Lenoir G., Lavin M.F., Tatsumi K., Wegner R.D., Shiloh Y., and Bar-Shira A. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5 (1996) 433-439
24. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., and Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 3 (2000) 206-211
25. Perry P., and Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 251 (1974) 156-158
26. Savage J.R.K. Classification and relationship of induced chromosomal structural changes. J. Med. Gen. 13 (1975) 103-122
27. Lioi M.B., Santoro A., Barbieri R., Salzano S., and Ursini M.V. Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat. Res. 557 (2004) 19-27
28. Shackelford R.E., Fu Y., Manuszak R.P., Brooks T.C., Sequeira A.P., Wang S., Lowery-Nordberg M., and Chen A. Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells. DNA Repair 5 (2006) 1327-1336
29. Puca F.M., Genco S., Specchio L.M., Brancasi B., D'Ursi R., Prudenzano A., Miccoli A., Scarcia R., Martino R., and Savarese M. Clinical pharmacodynamics of acetyl-l-carnitine in patients with Parkinson's disease. Int. J. Clin. Pharmacol. Res. 10 (1990) 139-143
30. Virmani A., and Binienda Z. Role of carnitine esters in brain neuropathology. Mol. Aspects Med. 25 (2004) 533-549
31. Jackson A.L., and Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477 (2001) 7-21
32. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., and Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal 4 (2002) 465-469
33. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., and Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from ATM-deficient mice. Cancer Res. 61 (2001) 1849-1854
34. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
35. Djuzenova C.S., Schindler D., Stopper H., Hoehn H., Flentje M., and Oppitz U. Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (comet) assay. Lab. Invest. 79 (1999) 699-705